The Role of Immunotherapy in Hepatocellular Carcinoma: A Systematic Review and Pooled Analysis of 2,402 Patients

BACKGROUND: Immune checkpoints inhibitors (ICIs) have emerged as a treatment option for several malignancies. Nivolumab, pembrolizumab, nivolumab plus ipilimumab, and atezolizumab plus bevacizumab have been approved for the management of advanced‐stage hepatocellular carcinoma (HCC). We aimed to sys...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Ziogas, Ioannis A., Evangeliou, Alexandros P., Giannis, Dimitrios, Hayat, Muhammad H., Mylonas, Konstantinos S., Tohme, Samer, Geller, David A., Elias, Nahel, Goyal, Lipika, Tsoulfas, Georgios
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2021
Assuntos:
Hepatobiliary
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8176986/
https://ncbi.nlm.nih.gov/pubmed/33314549
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/onco.13638
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados